Cystatin C for early detection of renal impairment in diabetes
- PMID: 18983837
- DOI: 10.1016/j.clinbiochem.2008.10.002
Cystatin C for early detection of renal impairment in diabetes
Erratum in
- Clin Biochem. 2011 Sep;44(13):1187. Mekhali, F [corrected to Mekahli, F]
-
Corrigendum to "Cystatin C for early detection of renal impairment in diabetes" [Clin. Biochem. 42 (2009) 108-110].Clin Biochem. 2011 Sep;44(13):1187. doi: 10.1016/j.clinbiochem.2011.06.001. Epub 2011 Jun 15. Clin Biochem. 2011. PMID: 30011748 No abstract available.
Abstract
Objectives: Evaluation of glomerular filtration rate is of crucial importance in diabetes. Cystatin C, a cysteine protease inhibitor seems to be an interesting parameter.
Design and methods: 67 diabetic patients with normal creatinine are evaluated. Cystatin C is compared to renal markers, by reference to Cr EDTA clearance.
Results: Significant correlations are found between cystatin C and creatinine (r=0.54). GFR MDRD (r=-0.47) and GFR Cr EDTA (r=-0.47). The AUC of the receiver operating curves is better for GFR MDRD (0.83) and cystatin C (0.75) than for creatinine (0.63) considering the cut off value of 80 mL/min for GFR EDTA.
Conclusion: Cystatin C seems to be a more sensitive parameter than creatinine for the detection of an incipient nephropathy in diabetes.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical